Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2018 Sep;5(9):691-692.
doi: 10.1016/S2215-0366(18)30295-5. Epub 2018 Aug 7.

Refining treatment choices for ADHD

Anne Arnett  1 , Mark Stein  2
Affiliations
Comment

Refining treatment choices for ADHD

Anne Arnett et al. Lancet Psychiatry. 2018 Sep.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Cortese S, Adamo N, Del Giovane C, et al. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. The Lancet Psychiatry. 2018;5(9):727–738. - PMC - PubMed
    1. Storebø OJ, Krogh HB, Ramstad E, et al. Methylphenidate for attention-deficit/hyperactivity disorder in children and adolescents: Cochrane systematic review with meta-analyses and trial sequential analyses of randomised clinical trials. Bmj. 2015;351:h5203. - PMC - PubMed
    1. Romanos M, Coghill D, Gerlach M, et al. Check and Double Check–the Cochrane review by Storebo et al.(2015) is indeed flawed. Zeitschrift für Kinder-und Jugendpsychiatrie und Psychotherapie. 2016. - PubMed
    1. Gordon M, Antshel K, Faraone S, et al. Symptoms versus impairment: the case for respecting DSM-IV’s Criterion D. Journal of attention disorders. 2006;9(3):465–475. - PubMed
    1. Sasser T, Schoenfelder EN, Stein MA. Targeting Functional Impairments in the Treatment of Children and Adolescents with ADHD. CNS Drugs. 2017;31(2):97–107. - PubMed